Publication | Open Access
Alveolar macrophages in early stage COPD show functional deviations with properties of impaired immune activation
42
Citations
85
References
2022
Year
Acute Lung InjuryPulmonary CareInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationMitochondrial DysfunctionImmunologyImmune RegulationPulmonary Alveolar ProteinosisCopd PatientsEarly Stage CopdInflammationPulmonary PharmacologyAllergyAlveolar MacrophagesPulmonary FibrosisPulmonary MedicineFunctional DeviationsCell BiologyPulmonary DiseasePhagocyteImmune Cell DevelopmentMedicineMatrikines
Despite its high prevalence, the cellular and molecular mechanisms of chronic obstructive pulmonary disease (COPD) are far from being understood. Here, we determine disease-related changes in cellular and molecular compositions within the alveolar space and peripheral blood of a cohort of COPD patients and controls. Myeloid cells were the largest cellular compartment in the alveolar space with invading monocytes and proliferating macrophages elevated in COPD. Modeling cell-to-cell communication, signaling pathway usage, and transcription factor binding predicts TGF-β1 to be a major upstream regulator of transcriptional changes in alveolar macrophages of COPD patients. Functionally, macrophages in COPD showed reduced antigen presentation capacity, accumulation of cholesteryl ester, reduced cellular chemotaxis, and mitochondrial dysfunction, reminiscent of impaired immune activation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1